In a recent study, macrophage-derived CCL17 drove tumor invasion by acting on the CCL17/CCR4/mTORC1 pathway, suggesting that chemokines secreted by non-tumor cells may positively favor the invasiveness of PitNETs. This evidence concerns the gene CCL17 and neoplasm.